Volume 9, Issue 4 (Vol.9 No.4 Jan 2021)                   rbmb.net 2021, 9(4): 490-497 | Back to browse issues page


XML Print


Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences.
Abstract:   (2729 Views)
Background: Various studies have shown that diabetes and its complications are associated with vitamin D deficiency. Due to the possible role of vitamin D in reducing the complications of diabetes and the high prevalence of its deficiency in Iran, this study was designed to investigate the effect of vitamin D supplementation on anthropometric indices and dietary intake of patients with type 2 diabetes.

Methods: This randomized clinical trial (RCT) study was performed on 74 patients with type 2 diabetes (T2DM). Patients randomly divided into two groups to receive vitamin D (VD) supplementation (100 μg or 4000 IU/day) or placebo for three months, randomization was based on the permutated-block method. Anthropometric indices including body weight (BW), body mass index (BMI) and waist circumference (WC) and physical activity, dietary intake were assessed by validated methods at the beginning and end of the trial.

Results: VD supplementation had not any significant differences in anthropometric indices, dietary intake and physical activity between the two groups.

Conclusions: Finally, it can be concluded, receiving 100 micrograms/day of VD for three months had no favourable effects on patients with T2DM.
Full-Text [PDF 561 kb]   (1321 Downloads)    
Type of Article: Case Report | Subject: Biochemistry
Received: 2020/05/29 | Accepted: 2020/06/23 | Published: 2021/03/8

References
1. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med. 2002;19(9):708-23. [DOI:10.1046/j.1464-5491.2002.00835.x] [PMID]
2. Franz MJ. Medical nutrition therapy for diabetes mellitus and hypoglycemia of nondiabetic origin. 2007.
3. Ogurtsova K, da Rocha Fernandes J, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40-50. [DOI:10.1016/j.diabres.2017.03.024] [PMID]
4. Cho N, Shaw J, Karuranga S, Huang Y, da Rocha Fernandes J, Ohlrogge A, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res clin Prac. 2018;138:271-281. [DOI:10.1016/j.diabres.2018.02.023] [PMID]
5. Esteghamati A, Etemad K, Koohpayehzadeh J, Abbasi M, Meysamie A, Noshad S, et al. Trends in the prevalence of diabetes and impaired fasting glucose in association with obesity in Iran: 2005-2011. Diabetes Res Clin Prac. 2014;103(2):319-27. [DOI:10.1016/j.diabres.2013.12.034] [PMID]
6. Association AD. Standards of Medical Care in Diabetes-2017: summary of revision. Diabetes care. 2017;40 (Suppl 1):S4-S5. [DOI:10.2337/dc17-S003] [PMID]
7. Espositi K, Maiorino MI, Ceriello A, Giugliano D. Prevention and control of type 2 diabetes by Mediterranean diet: a systematic review. Diabetes research and clinical practice. 2010;89(2):97-102. [DOI:10.1016/j.diabres.2010.04.019] [PMID]
8. Hosseinzadeh P, Javanbakht MH, SA Mostafavi, Djalali M, Derakhshanian H, Hajianfar H, et al. Brewer's Yeast Improves Glycemic Indices in Type 2 Diabetes Mellitus. Int J Prev Med. 2013; 4(10):1131-8.
9. Płudowski P, Karczmarewicz E, Bayer M, Carter G, Chlebna-Sokół D, Czech-Kowalska J, et al. Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe-recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol Pol. 2013;64(4):319-27. [DOI:10.5603/EP.2013.0012] [PMID]
10. Walsh JS, Bowles S, Evans AL. Vitamin D in obesity. Curr Opin Endocrinol Diabetes Obes. 2017;24(6):389-394. [DOI:10.1097/MED.0000000000000371] [PMID]
11. Fleet JC, DeSmet M, Johnson R, Li Y. Vitamin D and cancer: a review of molecular mechanisms. Biochem J. 2012;441(1):61-76. [DOI:10.1042/BJ20110744] [PMID] [PMCID]
12. Nadimi H, Djazayery A, Javanbakht MH, Dehpour A, Ghaedi E, Derakhshanian H, et al. The Effect of Vitamin D Supplementation on Serum and Muscle Irisin Levels, and FNDC5 Expression in Diabetic Rats. Reports of Biochemistry & Molecular Biology. 2019;8(3):236-243.
13. Sung C-C, Liao M-T, Lu K-C, Wu C-C. Role of vitamin D in insulin resistance. J Biomed Biotechnol. 2012:634195. [DOI:10.1155/2012/634195] [PMID] [PMCID]
14. Gagnon C, Lu ZX, Magliano DJ, Dunstan DW, Shaw JE, Zimmet PZ, et al. Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab). J Clin Endocrinol Metab. 2012;97(6):1953-61. [DOI:10.1210/jc.2011-3187] [PMID]
15. Grineva E, Karonova T, Micheeva E, Belyaeva O, Nikitina I. Vitamin D deficiency is a risk factor for obesity and diabetes type 2 in women at late reproductive age. Aging (Albany NY). 2013;5(7):575-81. [DOI:10.18632/aging.100582] [PMID] [PMCID]
16. Sneve M, Figenschau Y, Jorde R. Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects. European journal of endocrinology. 2008;159(6):675-684. [DOI:10.1530/EJE-08-0339] [PMID]
17. Shab-Bidar S, Neyestani TR, Djazayery A, Eshraghian MR, Houshiarrad A, Gharavi A, et al. Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double-blind clinical trial. BMC Med. 2011;9:125. [DOI:10.1186/1741-7015-9-125] [PMID] [PMCID]

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.